Pacific Biosciences of Californ - Payout Ratio History
Payout ratio history for stock PACB (Pacific Biosciences of Californ).
| Date | Payout ratio |
|---|---|
| December 2020 | -281.49% |
| November 2020 | -240.60% |
| October 2020 | -240.60% |
| September 2020 | -240.60% |
| August 2020 | -232.76% |
| July 2020 | -232.76% |
| June 2020 | -232.76% |
| May 2020 | -103.90% |
| April 2020 | -103.90% |
| March 2020 | -103.90% |
| February 2020 | -103.90% |
| January 2020 | -103.90% |
| December 2019 | -103.90% |
| November 2019 | -103.90% |
| October 2019 | -103.90% |
| September 2019 | -103.90% |
| August 2019 | -103.90% |
| July 2019 | -103.90% |
| June 2019 | -103.90% |
| May 2019 | -103.90% |
| April 2019 | -103.90% |
| March 2019 | -103.90% |
| February 2019 | -103.90% |
| December 2018 | -90.91% |
PACB
Price: $1.47
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.21 USD
P/E Ratio: -5.11
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 5.8 million
Ebitda: -20.1 millionMarket Capitalization: 892.3 million